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Abstract
Background: Three spin-labeled mutant proteins, mutated at the beginning, middle, and end of α-
helix 5 of the Bacillus thuringiensis Cry1Ab δ-endotoxin, were used to study the involvement of
these specific amino acid residues in ion transport and to determine conformational changes in the
vicinity of these residues when the protein was translocated into a biological membrane.
Results: Amino acid residue leucine 157, located in the N-terminal portion of α-helix 5, showed
no involvement in ion transport, and the environment that surrounds the residue did not show any
change when transferred into the biological membrane. Serine 170, located in the middle of the α-
helix, showed no involvement in ion transport, but our findings indicate that in the membrane-
bound state this residue faces an environment that makes the spin less mobile, as opposed to the
mobility observed in an aqueous environment. Serine 176, located in the C-terminal end of the α-
helix 5 is shown to be involved in ion transport activity.
Conclusion: Ion transport data for L157, S170, and S176, along with the mobility of the spin-labels,
structural characterization of the resulting proteins, and toxicity assays against a target insect,
suggest that the toxin undergoes conformational changes upon protein translocation into the
midgut membrane. These conformational changes result in the midregion of the α-helix 5 being
exposed to a hydrophobic-like environment. The location of these three residues in the toxin
suggests that the entire α-helix becomes inserted in the insect midgut membrane.
Background
Identification of the amino acid residues involved in the
ion transport activity of Bacillus thuringiensis (Bt) δ-endo-
toxins remains an interesting challenge. The δ-endotoxins
are insecticidal crystal proteins (ICPs) produced by the
bacterium during the sporulation stage [1]. The ICPs are
composed of several proteins (also known as Cry toxins)
with insecticidal activity against insects of the orders Lep-
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are dissolved in the insect midgut to release the protoxin
form of the proteins. The action of proteases in the insect
midgut cleaves the protoxin at specific locations, releasing
the toxic fragment of the protein. In the case of the lepi-
dopteran-specific Cry1A δ-endotoxins, the protoxins have
a molecular weight of approximately 140 kDa, while the
molecular weight of the toxic fragment is approximately
65 kDa [1].
The toxic action of the protein is initiated by the binding
of the active fragment to receptors located on the mem-
brane lining the insect midgut. It has been suggested that
after binding to the receptors, the toxin induces ion pores
capable of disrupting the membrane potential [2,3]. The
molecular events occurring between binding and intoxica-
tion remain unclear. Some authors proposed that the
binding to these receptors triggers conformational
changes that allow the protein to translocate into the
membrane, becoming inserted into the lipid moiety [4,5];
such conformational changes, and the membrane bound
state of the toxin have not yet been elucidated.
Cry1Ab δ-endotoxin is one of the many insecticidal toxins
expressed by Bacillus thuringiensis. The three dimensional
structure of Cry1Aa (a protein with 89% sequence homol-
ogy to Cry1Ab), is composed of three structural domains
[4]. Domain I is formed by an α-helix bundle formed by
seven helices with the α-helix 5 located in the core of the
domain. Domains II and III are mainly composed of β-
sheets. There is evidence that at least α-helix 7, located in
Domain I, is involved in the ion transport activity [6,7].
Domains II and III are involved in receptor recognition in
the insect midgut [8,9].
The insertion of the toxin into lipid membranes has been
studied using artificial phospholipid vesicles, lipid bilay-
ers [10,11], modified protein toxins in artificial mem-
branes [3], and artificial peptides resembling structural
motifs of the protein [12,13]. The protection of δ-endo-
toxins against proteinase K (Pk) digestion in the presence
of brush border membrane vesicles (BBMV) has been
used to study the insertion process of the toxin into sys-
tems resembling the midgut environment [14-17].
Site-directed spin-labeling (SDSL) in combination with
electron paramagnetic resonance (EPR) spectroscopy is a
powerful technique for analyzing the dynamic and struc-
tural properties of membrane proteins [18]. To use this
technique, specific amino acid residues are mutated into
cysteine residues, and then labeled with paramagnetic rea-
gents using the introduced cysteine as the reactive site
[19]. For the present study we have used site-directed
mutagenesis to introduce single cysteine residues at three
positions in the α-helix 5 of Bt Cry1Ab (Figure 1). Mutant
toxins L157C (N-terminal region), S170C (centrally
located) and S176C (C-terminal region) were studied by
SDSL, voltage clamping (Vc) and circular dichroism (CD)
spectroscopy, among other techniques. Our results indi-
cate that only the C-terminally-located spin-label has an
effect in the ion transport activity of the toxin in Manduca
sexta (M. sexta) larvae, without any effect on the structure
or the structural stability of the toxin, while the central
hydrophobic face of the α-helix becomes inserted in the
membrane or another hydrophobic environment that
decreases the mobility of the spin-label.
Results
Expression of proteins in E. coli, purification and bioassays
Each of the mutations produced protoxins, as determined
by SDS (10%)-PAGE (Figure 2, panel A). Tryptic digestion
Three-dimensional representation of B. thuringiensis Cry1Ab δ-endotoxin howing th  mutations introduced in α-Helix 5(black in the figure)Figure 1
Three-dimensional representation of B. thuringiensis 
Cry1Ab δ-endotoxin showing the mutations intro-
duced in α-Helix 5 (black in the figure). L157 is located 
at the N-terminal end of the helix (red spheres), S170 in the 
middle of the helix (blue spheres) and S176 at the C-terminal 
end (green spheres). The inset shows a view of the toxin 
from top of the α-helical domain to indicate the central loca-
tion and the orientation of the amino acid residues mutated 
for this study.
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a size identical to that from wild type Cry1Ab (Figure 2,
panel B). Toxicity assays indicate that the toxicity level of
S170C (LC50 = 40.24 ng/cm2) is almost identical to
Cry1Ab wild type (LC50 = 36.00 ng/cm2) with overlapping
confidence limits (see Table 1). Mutant toxins L157C and
S176C exhibit decreased toxicities by a factor of 2- and
1.5-fold, respectively. The confidence limits for all three
toxins overlapped, however, indicating that there were no
significant changes in toxicity as determined by this assay.
These results, which showed similar toxicities when the
confidence limits were considered, did not agree with the
results obtained by Vc, as shown in Table 1. The correla-
tion between toxicity and the location of the residue in the
α-helix 5 was more interesting when the bioassays were
performed with the cysteine residue blocked with the MTS
spin-label. In this case, S170R1 (LC50 = 42.61 ng/cm2) and
L157R1 (LC50 = 101.75 ng/cm2) showed no difference
from the non-labeled mutant protein. The toxicity of the
S176R1 (LC50 = 130.68 ng/cm2) mutant decreased by
more than two-fold compared to the non-labeled mutant
toxin, indicating that the spin-label at C176 affected the
toxicity of the protein.
Voltage clamping
Voltage clamping analysis was performed to determine
whether the introduced mutations affected the ion trans-
port activity of the toxin, which in turn is directly corre-
lated with toxicity ([6], see inset in Figure 3A). The LC50
values for L157C and S170C have similar values to
L157R1 and S170R1, respectively, as shown above. Similar
results were seen when the Vc experiments were per-
formed with spin-labeled toxins, indicating that the labe-
ling of these two residues does not affect their toxic
activity (Figure 3). When mutant toxin S176C was assayed
without the MTS-SL, it showed a decrease in the insertion
time (T0 = 6.84 ± 0.15 min) compared to the wild-type
Cry1Ab (T0 = 4.00 ± 0.14 min), and the ion transport
activity was slower (as determined by the slope of Isc inhi-
bition versus time, see inset in Figure 3A), in accordance
with a two-fold decrease in toxicity. When the toxicity pro-
duced by this protein was assayed with the spin-label
attached to the protein, the insertion time was signifi-
cantly longer (T0 = 14.0 ± 0.15 min) and the ion transport
was even slower (slope = -3.39 ± 0.12 μA/min), compared
with the wild-type toxin (slope = -13.42 ± 0.70 μA/min)
and the non-labeled S176C mutant toxin (slope = -5.56 ±
0.10 μA/min).
Table 1: Toxicity assays and voltage clamping parameters
Toxin aLC50 ng/cm2 bSlope, μA/min cT0 min.
Cry1Ab 36.00
(19.9-57.8)
-13.42 ± 0.70
-10.93 ± 0.27d
4.00 ± 0.14
4.22 ± 0.12d
L157C 78.60
(51.3-143.3)
-7.03 ± 0.22 7.58 ± 0.60
L157R1 101.75
(95.65-107.85)
-4.27 ± 0.80 8.04 ± 0.20
S170C 40.24
(27.17-56.16)
-11.85 ± 0.60 3.93 ± 0.60
S170R1 42.61
(31.76-56.31)
-10.73 ± 0.20 3.08 ± 0.60
S176C 62.15
(34.00-92.90)
-5.56 ± 0.10 6.84 ± 0.15
S176R1 130.68
(125.06-136.75)
-3.39 ± 0.12 14.00 ± 0.10
a: 50% Lethal doses concentration, numbers in parenthesis represent 
95% confidence limits.
b: Slope: was obtained by fitting the straight portion of the curve to a 
linear equation.
c: T0, defined as the insertion time. This was calculated with equation 
(1).
d: Cry1Ab wild type toxin in the presence of MTS spin-label.
SDS-PAGE analysis of wild type and mutant toxinsFigure 2
SDS-PAGE analysis of wild type and mutant toxins. 
Panel A, shows the protoxins, and panel B shows the toxins. 
Lane 1, Cry1Ab wild type; lane 2, L157C; lane 3, S170C; lane 
4, S176C and lane 5, molecular weight marker.
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transport activity are likely to occur as a result of capping
the cysteine residue with the spin-label since such changes
were not found in the other two mutant proteins. The
mutant toxin S170C showed the same ion transport activ-
ity either with or without capping of the cysteine residue
(see Table 1), and these parameters (slope = - 11.85 ± 0.60
μA/min, T0 = 3.93 ± 0.60 min) are similar to those of the
wild type toxin (slope = -13.42 ± 0.70 μA/min, T0 = 4.00 ±
0.14 min). On the other hand, mutant toxin L157C
showed a small decrease in ion transport that reflects the
decrease observed in LC50 with no observable change in
the insertion time (see Table 1). The parameters obtained
for L157C mutant protein suggest that this toxin has a
reduced ability to transport ions (slope = -7.03 ± 0.22 with
no MTS-SL and slope = - 4.27 ± 0.80 with MTS-SL, with no
change in the insertion time). The results obtained from
the voltage clamp experiments are in agreement with the
relative toxicities calculated from the toxicity assays (see
inset in Figure 3A). These results suggest that the change
in slope and insertion time (i.e., toxicity) observed for
S176C is due to the particular location of the S176 resi-
due, which is therefore critical for ion transport or for par-
titioning of the toxin in the membrane.
Circular dichroism spectroscopy and thermal analysis
To determine whether structural and stability changes
were introduced into the secondary structure of the toxin,
either by the mutation or the spin-label, thermal and the
CD spectral analyses of S176C were performed (Figure 4).
It can be seen that the secondary structures of S176C and
S176R1 are identical to the secondary structure of the wild-
type toxin, with characteristic absorbance peaks at λ = 208
and 220 nm, indicating that neither the mutation, nor the
spin-label introduced any observable changes in the sec-
ondary structure of the toxins. The thermal stability anal-
ysis (shown in Figure 5) shows a typical unfolding curve
for Cry toxins, with a very stable native population that
starts showing signs of unfolding above 65°C and reaches
a fully unfolded population at approximately 90°C, with
a Tm ≈ 76°C.
EPR spectroscopy in solution and in BBMV
The EPR spectrum of a spin-label is sensitive to the envi-
ronment surrounding the nitroxide [18-22]. For this rea-
son, a spin-labeled protein in solution is expected to
display a different EPR signal than one in a hydrophobic
environment, either in a biological membrane or a pro-
tein core, assuming that the conditions surrounding the
Voltage Clamping AnalysisFigur 3
Voltage Clamping Analysis. Panel A, wild type Cry1Ab 
protein and cysteine mutants without MTS-SL. Panel B, wild 
type protein and cysteine mutants with the cysteine reacted 
with MTS-SL. The dashed line shows the time when each 
toxin was added to the chamber. The inset shows the slope 
calculated from equation (1), plotted against the toxicity 
determined with the bioassays; indicating that there is a 
direct correlation between toxicity levels and ion channel 
activity for these toxins.
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Circular dichroism analysis of Cry1Ab, S176C and the spin-labeled mutant protein, S176R1Figure 4
Circular dichroism analysis of Cry1Ab, S176C and 
the spin-labeled mutant protein, S176R1.
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the present work we analyzed the EPR spectra of the
mutant toxins in solution and in brush border membrane
vesicles prepared from M. sexta midgut tissue. Spectra of
each spin-labeled protein in solution were taken at room
temperature in a flat cell. Each sample was then trans-
ferred to a 1.5 mL vial containing 2.0 mg of BBMV in 250
μL binding buffer, where the mixture was incubated for 45
min at room temperature and transferred back into the
cell. The new spectrum was recorded and compared with
the data acquired in solution. The EPR spectra for L157R1,
S170R1 and S176R1 are shown in Figure 6. The spectra for
L157R1 and S170R1 reflect an environment of low mobil-
ity, both in the membrane and in solution. The shapes of
these spectra agree with the location of the corresponding
amino acids in the protein (Figure 1). The spectrum for
S176R1 displays a more mobile spin-label, which is also in
agreement with the location of the spin-label in the exter-
nal end of domain I. The spectra of the labeled toxins in
the membrane show that only the S170R1 mutant has
changed to a less mobile state in the membrane-bound
configuration, although almost no change is observed in
the toxicity parameters or the ion transport abilities of the
toxin. The insertion of the spin-labeled toxin in the mem-
brane was confirmed by performing bioassay and Vc
experiments with spin-labeled toxins. The EPR spectra of
the spin-labeled proteins in solution and in the mem-
brane-bound state were analyzed. The results are shown in
Figure 6. It is seen that the spectra of L157R1 and S176R1
in solution are identical to those in the membrane, indi-
cating that there were no changes in the environment of
the nitroxide (Figures 6A and 6C). In other words the
nitroxide environment was transferred intact from the
solution into the membrane. In contrast, the EPR spec-
trum for S170R1 indicates that the nitroxide is less mobile
when the toxin is inserted into the membrane (Figure 6B).
Continuous wave (CW) power saturation was used to
examine whether the S176R1 protein was able to penetrate
the membrane, as was suggested by the ion transport
properties of the mutant. The results, shown in Figure 7,
indicate that in the membrane-bound state (Figure 7B)
spin exchange between the oxygen and the nitroxide is
larger than the exchange with NiEDDA, suggesting that
the spin-labeled residue becomes inserted in the mem-
brane. This is in contrast with solution conditions, where
exchange with NiEDDA is larger than with oxygen (Figure
7A), suggesting exposure of the nitroxide to the aqueous
environment in agreement with the solution structure of
the protein. The information presented above suggests
that serine 176 is involved in the ion transport capabilities
of the toxin, although the exact location of this residue
with respect to the resulting pores has not yet been deter-
mined. Based on the calibration curve published by Oh et
al. [23] our data suggest that the depth of the spin-label
from the membrane surface is between 4.0 and 5.0 Å.
Thermal denaturation analysis of mutant toxin S176C and the spin-labelled mutant protein, S176R1Figure 5
Thermal denaturation analysis of mutant toxin 
S176C and the spin-labelled mutant protein, S176R1.
EPR spectral analysis of the spin-labelled mutant toxins L157C, S170C nd S176C in solution and in the membraneFigure 6
EPR spectral analysis of the spin-labelled mutant tox-
ins L157C, S170C and S176C in solution and in the 
membrane. The dashed line represents the spectra in solu-
tion, while the dark line shows the spectra in the membrane. 
The spectra L157R1 and S176R1 in the membrane overlap 
with the corresponding spectra in solution. The spectra for 
S170R1 show small variations in the membrane-bound state, 
with clear narrowing at position a.
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ence of membrane proteins, carbohydrates and a great
variety of phospholipids in the BBMV. Thus a calibration
curve to determine distances in BBMV should be con-
structed if the scanning of additional spin-labeled pro-
teins is intended.
Discussion
Studies on the mode of action of the Bt δ-endotoxins have
shown that this is a rather complex mechanism that
involves the identification of the target tissue by the acti-
vated toxin, followed by association to membrane recep-
tors and internalization into the membrane. The regions
of the toxin responsible for membrane internalization
and ion transport, and the active conformation of the
toxin in the membrane, have not yet been determined. In
the present work, we used a combination of site-directed
spin-labeling and voltage clamping to address these
issues.
Three amino acid residues located in the postulated ion-
transport region were individually mutated to cysteine.
Each resulting toxin was tested for structural stability and
biological activity. Amino acid residue L157 is located at
the N-terminal end of the centrally-located α-helix 5,
S170 is located at the middle, and S176 at the C-terminal
end of the helix (Figure 1). The three mutated proteins
produced stable protoxins with the same size as the wild
type toxin (Figure 2A); after tryptic digestion, each pro-
toxin released the stable toxin of the same size as the wild
type Cry1Ab (Figure 2B). The biological effect of each
introduced mutation was first analyzed by bioassays on
M. sexta larva. Results show that S170C has the same tox-
icity as the wild type toxin while L157C and S176C show
a small reduction (about 2-fold decrease). Although the
LC50values for L157C and S176C clearly show that these
two proteins are less toxic than the wild type, the overlap-
ping confidence limits indicate that these bioassays are
not accurate enough to determine toxicity differences
within such a close range.
To determine more accurately the effects of the mutations
on the toxicity, we analyzed the ion transport activity of
the toxins by voltage clamping. Our results showed that
mutation S170C had no effect at all in ion transport,
while mutations L157C and S176C decreased the ion
transport activity of the toxins (Figure 3A). Calculated val-
ues from the voltage clamping curves are shown in the
table. The toxins were compared by analyzing their slopes
and insertion times [6,14]. Both the slope and the inser-
tion time for S170C were almost identical to those of the
wild type, while these parameters indicated a reduction in
ion transport and insertion time for L157C and S176C.
The accuracy of the voltage clamp was reflected in the cor-
relation between the LC50 values and ion transport, as
shown in the insert on Figure 3A, in which a plot of LC50
vs. slope shows a linear correlation.
To assess the effects of the spin-label on the biological
properties of the toxins, each mutant toxin was reacted
with MTS-SL, non-attached MTS was removed, and the
bioassay and voltage clamping experiments were carried
out. The S170R1 mutant toxin showed no change either in
toxicity or ion transport. The L157R1 mutant toxin
showed a slight decrease in toxicity, which correlates with
extent of loss of ion transport activity. On the other hand,
the S176R1 mutant showed a large decrease in both the
toxicity and the ion transport that are statistically signifi-
cant. One possible reason why this mutant was less active
when the cysteine residue was modified with the spin-
label could have been the introduction of large conforma-
tional changes due to the bulky side chain. The longer
insertion time of the S176R1 mutant could also be due to
steric limitations introduced by the modified side chain.
Once the protein has been inserted, the ion transport
should resemble the activity of S176C provided that the
amino acid is not involved in this function. However, the
slope of a plot of Isc vs. time, obtained from voltage clamp
CW power saturation for S176R1 mutant toxin in A) Solu-tion and B) in M. sexta BBMV, in the presence of itrogen, oxyge  and NiEDDA, as indicatedFigure 7
CW power saturation for S176R1 mutant toxin in A) 
Solution and B) in M. sexta BBMV, in the presence of 
nitrogen, oxygen and NiEDDA, as indicated.
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amino acid residue at position 176 was involved in ion
transport.
CD was used to analyze structural changes in toxin struc-
ture. The CD spectra showed that there were no changes
in any of the structures, with or without the spin-label.
The particular situation of S176R1, which showed a con-
siderable decrease in ion transport, indicated that neither
the mutation, nor the presence of the spin-label had any
effect on the secondary structure (Figure 4). CD thermal
melting was used to determine whether the spin-label had
introduced any structural instability in the protein. As
shown in Figure 5, the thermal melting curve of the
S176R1 mutant overlaps with the thermal melting curve of
the S176C mutant, with a Tm = 76°C, the same as the wild-
type toxin.
By analyzing the conformation of the protein in solution,
as shown in Figure 1, it is clear that some conformational
changes must accompany the transfer of the protein from
solution into the lipid moiety, so the S170 residue
becomes located in a more viscous environment that
restricts the tumbling seen in solution. One possible
explanation, in agreement with two previous publications
in which α-helix 5 is proposed to anchor to the membrane
moiety [24,25], would be that, after α-helix 1 is cut out of
the structure [16], α-helices 2 and 3 open up exposing the
hydrophobic face of α-helix 5 to the hydrophobic moiety
of the membrane. This would explain why the motion of
the modified 170 residue becomes more restricted in the
membrane-bound state. It is also possible, however, that
location of the spin-label in a hydrophobic environment
dominated by hydrophobic amino acids would produce
similar observations.
It is clear that the combination of site-directed spin-labe-
ling and voltage clamping allows the determination of
functional amino acid residues involved in ion transport
activity of the Bt δ-endotoxins, and gives information
about the membrane-bound conformation of these
important insecticidal toxins. Two very important aspects
of this combination of methodologies are, first, that volt-
age clamping allows for experiments on the midgut tissue
containing functional receptors in their native environ-
ment and, second, that EPR gives information on the spin-
labeled proteins inserted in BBMV. This is in contrast to
results obtained from artificial phospholipid vesicles in
which the receptors and the structure of the membrane are
not necessarily the same as in the biological organism.
Along with these advantages, the EPR experiments can
also be carried out in artificial phospholipid vesicles.
These experiments would allow one to determine the
effects of membrane proteins on the EPR spectrum of the
spin-labeled toxin.
Conclusion
It has long been debated whether the different α-helices in
domain I of Bt δ-endotoxins undergo conformational
changes which allow them to accommodate to the hydro-
phobic environment of the insect midgut. The data pre-
sented here support this hypothesis, and suggest that α-
helix 5 spans the membrane with the terminal end-
located residues (L157 and S176) facing either the water
side of the pore or the aqueous environment outside the
membrane, and the mid region residue (S170) facing a
hydrophobic environment that restricts the mobility of
the spin-label. Since this helix is in the middle of the α-
helical bundle, to account for this change in spin-label
mobility, this conformational change requires that the
whole domain re-accommodates upon protein transloca-
tion into the midgut membrane. A possible model for the
membrane-bound state of α-helix 5 is shown in Figure 8.
Methods
Site-directed mutagenesis, toxin preparation and analysis
Selection of the amino acid residues to be targeted for
mutagenesis was based on the Cry1Ab protein structure
modeled from Cry1Aa (Pdb code 1CIY), whose crystal
structure is available [4]. The coordinates for Cry1Aa were
used as template to introduce the changes needed to trans-
form Cry1Aa into Cry1Ab with the protein tools included
in the program QUANTA (Molecular Simulations, Inc.).
Each mutation was energy minimized to Root Mean
Square (R.M.S.) of 0.1 using a Polak-Ribiere algorithm
with the force field MM+ (Hypercube, Inc.). Mutant toxins
L157C, S170C and S176C were constructed by site-
directed mutagenesis as described [26]. The plasmid con-
taining the target mutation was transformed into E. coli
MV1190 (BioRad) and purified as described [26]. The
protoxin form of the proteins was extracted from the
inclusion bodies by dissolving the crystals in 50mM car-
bonate buffer, pH 10.5, at 37°C with constant agitation
for 2.0 hours. The presence of the protein was confirmed
with SDS (10%)-PAGE gels. Toxins were obtained by
digesting the protoxins in 1/20 protoxin/trypsin (w/w)
ratio at 37°C for 2.0 hours. The digestion step was
repeated under the same conditions. The toxins were puri-
fied by size-exclusion chromatography using an Akta
Explorer workstation (GE Healthcare, Piscataway, NJ)
with a GE Healthcare HiLoad 16/60 Superdex200 col-
umn.
Bioassays
Bioassays and other experimental procedures were per-
formed following guidelines approved by the Institu-
tional Animal Care and Use Committee of the Ohio State
University. Toxicity levels were determined with the diet
surface contamination assay. For this assay, 24 well sterile
dishes (Falcon) were half filled with artificial diet (Bios-
erv, Frenchtown, NJ). Five dilutions of the toxin were pre-Page 7 of 10
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cm2, and 50 μL of each dilution was poured on the surface
of the food. Two (2-3 days old) M. sexta larvae were placed
in each well and the lethality was scored after five days.
The lethal concentration killing 50% of the larvae (LC50)
was calculated with the program SoftTox (WindowChem
Software, Inc.). Each assay was repeated three times.
Electrophysiology
The inhibition of short circuit current (Isc) by toxin in M.
sexta midguts was measured by voltage clamping (Vc) fol-
lowing a procedure described by Harvey et al. [27]. Briefly,
the anterior portions of early 5th instar M. sexta midguts
were placed in membrane holders having a surface area of
about 0.44 cm2. Both sides of the tissue were constantly
bathed in oxygenated buffer. The current was measured
with a DVC-1000 voltage/current clamp (World Precision
Instruments). Twenty μL of toxin (concentration 25 ng/
μL) was added on the lumen side of the tissue after the Isc
current had been stable for approximately 20 minutes.
The data recorded in this way were normalized to % of Isc
remaining and fitted with the equation
where Isc is the short circuit current as function of time, Isc0
is the Isc value at the time when toxin is injected in the
chamber, t0 is the time needed for the current to drop 50%
from the initial value and A and b are fitting parameters.
The time needed for the current to drop 10% from the ini-
tial value, as calculated from equation (1), was considered
to be proportional to the insertion time, T0. Experiments
for each toxin were repeated at least three times. The slope
corresponding to the Isc between 20% and 80% was calcu-
lated with the program Sigma-Plot (Jandel Scientific Cor-
poration, Inc.) and was taken to be proportional to the
ion-transport activity of the toxin. To test the effect of the
introduced cysteine mutations the residues were reacted
with MTS as explained below, using EPR spectroscopy.
Circular dichroism spectroscopy and thermal analysis
Proteins for CD analysis were purified as explained above
using 40 mM phosphate buffer, pH 7.4 as mobile phase.
Thirty μg of toxin was analyzed in a 1.0 cm path length
Hellma quartz cuvette, in the range λ = 200-250 nm at
room temperature in an Aviv 62DS spectrometer. The
thermal melting analysis was done by increasing the tem-
perature from 30 to 90°C in 3°C increments. The equili-
bration point was determined by the program IGOR,
which controls the CD spectrometer. The CD spectrum for
melting analysis was taken at λ = 223 nm.
EPR Spectroscopy and continuous wave (CW) power 
saturation
[1-Oxyl-2,2,5,5-tetramethyl-D-pyrroline-3-methyl] meth-
anethiosulfonate (MTS) was from Toronto Research
Chemicals (Toronto, Canada). Samples for EPR spectra
were purified as described above. After purification the
samples were dialyzed against 4,000 volumes of 20 mM
Tris-HCl, 1.0 mM EDTA, 150 mM NaCl, pH 7.4 for 4 days
I I
A
e
t t
b
sc = −
+
−
−⎛
⎝⎜
⎞
⎠⎟
sc0
1
0 (1)
Model of the membrane-bound α-Helix 5Figure 8
Model of the membrane-bound α-Helix 5. The structural transformation suggested by the use of spin-labelled α-helix 5, 
indicates that this helix participates asymmetrically in the ion channel activity of the toxin. In the membrane-bound state 
Ser176 is part of the ion pore, while Leu157 is not. In contrast, amino acid Ser170 changes from a mobile to a less-mobile con-
formation.
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the samples formed a white precipitate that could be eas-
ily removed from solution by centrifugation. To spin-label
the protein, each sample was mixed with 5.0 molar excess
MTS spin-label reagent and allowed to react for 12 hours
at room temperature. Excess reagent was removed by dial-
ysis under the same conditions as above, followed by cen-
trifugation at 12,000 RPM for 15 minutes. HPLC analysis,
as described, was used to determine that the samples used
in all of the different assays were in a monomeric form.
Samples were concentrated to 0.1 mM, and a 200 μL aliq-
uot was loaded into a flat cell. Spectra were recorded using
a Bruker ESP300 EPR spectrometer at room temperature.
The resulting spectra were the average of 20 scans.
For CW power saturation, the NiEDDA was synthesized
following a protocol kindly provided by Dr. Jim Feix
(Medical College of Wisconsin). The samples were loaded
into gas permeable TPX capillaries and the data collected
in a loop-gap resonator. The collision parameter Π was
measured by power saturation as previously described
[20,21], with incident microwave power ranging from 0.1
to 40 mW. Briefly, the peak to peak amplitude (H) of the
resonance line as function of the incident microwave
power was fitted to equation (2) [20]
where P is the incident microwave power, P1/2 is the power
at which H is half of the unsaturated value, ε is a factor
related with the homogeneity of the line, and I is a scaling
factor [21]. P1/2 was determined in the absence of para-
magnetic species, in the presence of oxygen and in the
presence of 40 mM NiEDDA and the change in P1/2, ΔP1/
2, was determined from these measurements as described
by Altenbach et al. [20].
List of Abbreviations
Bt: Bacillus thuringiensis; BBMV: brush border membrane
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spin-labeling; MTS-SL: [1-oxyl-2,2,5,5-tetramethyl-D-pyr-
roline-3-methyl]methanethiosulfonate spin-label; Vc:
voltage clamping; Pk: proteinase K.
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